Viatris drops in late session volume surge, last off 3.4%

Viatris Inc. (VTRS) declined in late-session trading, with shares down 3.4% as of the latest available data. The stock closed at $14.92, a drop of $0.78 from its previous close of $15.70. The decline continued a broader trend of volatility in the healthcare sector, with Viatris among the day’s more significant performers.

The selloff came amid mixed signals from the company’s recent financial performance. While Viatris reported Q2 revenue of $3.76 billion and raised its full-year guidance, it also faces pricing pressures and operational disruptions. Additionally, the company has undertaken strategic divestitures and portfolio reshaping, which have contributed to uneven top-line momentum.

Investor sentiment appears cautious, with Weiss Ratings assigning VTRS a D rating and "Sell" recommendation. The downgrade reflects concerns over weak growth, poor efficiency, and a negative profit margin of -24.57%. Despite a 34.13% year-to-date return, the stock has underperformed relative to its three- and five-year returns compared to the S&P 500.

With the stock trading near the middle of its 52-week range and below its recent peak of $16.47, investors are closely watching for signs of stabilization or further deterioration. Key support levels and upcoming catalysts, such as potential regulatory decisions on pipeline products, will likely influence near-term direction.